Aclarion Valuation Multiples

Discover revenue and EBITDA valuation multiples for Aclarion and similar public comparables like NRGene, Pheton Holdings, HeartSciences, AMA Corp and more.

Aclarion Overview

About Aclarion

Aclarion Inc is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (MRS), and a proprietary biomarker to optimize clinical treatments. Its product Nociscan is a SaaS platform that leverages MR Spectroscopy to noninvasively help physicians distinguish between painful and nonpainful discs in the spine. The company derives its revenues from one source, the delivery of Nociscan reports to medical professionals. Substantially all revenues are generated from contracts with customers in the United States.


Founded

2015

HQ

United States

Employees

6

Financials (LTM)

Revenue: $116K
Net Income: ($9M)

Market Cap

$8M

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Aclarion Financials

Aclarion reported last 12-month revenue of $116K.

In the same LTM period, Aclarion generated $34K in gross profit and had net loss of ($9M).


Aclarion P&L

In the most recent fiscal year, Aclarion reported revenue of $76K and EBITDA of ($7M).

Aclarion is unprofitable as of last fiscal year, with gross margin of 9%, EBITDA margin of (9794%), and net margin of (9552%).

See analyst estimates for Aclarion
LTMLast FY202320242025202620272028
Revenue$116K$76K$75K$46K$76K
Gross Profit$34K$7K($0K)($39K)$7K
Gross Margin29%9%(0%)(85%)9%
EBITDA-($7M)($4M)($6M)($7M)
EBITDA Margin-(9794%)(5491%)(13700%)(9794%)
EBIT Margin(8108%)(9313%)(6468%)(12057%)(9313%)
Net Profit($9M)($7M)($5M)($7M)($7M)
Net Margin(8085%)(9552%)(6513%)(15294%)(9552%)

Financial data powered by Morningstar, Inc.

Aclarion Stock Performance

Aclarion has current market cap of $8M.

Market Cap Evolution


Aclarion's stock price is $2.74.

Aclarion has an EPS (earnings per share) of $-2.51.

See more trading valuation data for Aclarion
Market CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$8M11.4%---$-2.51

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Aclarion Valuation Multiples

Aclarion trades at (72.1x) EV/Revenue multiple, and 1.1x EV/EBITDA.

See NTM and 2027E valuation multiples for Aclarion

Aclarion Financial Valuation Multiples

As of August 18, 2026, Aclarion has market cap of $8M.

Aclarion has a P/E ratio of (0.8x).

LTMLast FY202320242025202620272028
EV/Revenue(72.1x)(110.8x)(111.2x)(183.4x)(110.8x)
EV/EBITDA-1.1x2.0x1.3x1.1x
EV/EBIT0.9x1.2x1.7x1.5x1.2x
EV/Gross Profit(248.7x)n/mn/m215.4xn/m
P/E(0.8x)(1.1x)(1.6x)(1.1x)(1.1x)
EV/FCF-1.1x2.2x1.5x1.1x

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Aclarion Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Aclarion Margins & Growth Rates

Aclarion grew revenue by 85% and net profit by 48% in the last fiscal year.

In the most recent fiscal year, Aclarion reported gross margin of 9%, EBITDA margin of (9794%), and net margin of (9552%).

See estimated margins and future growth rates for Aclarion

Aclarion Margins

Last FY202420252026202720282029
Gross Margin9%(85%)9%36%
EBITDA Margin(9794%)(13700%)(9794%)-
EBIT Margin(9313%)(12057%)(9313%)(7714%)
Net Margin(9552%)(15294%)(9552%)(7643%)
FCF Margin(9729%)(12233%)(9729%)-

Aclarion Growth Rates

FY+1/FY23/2424/2525/2626/2727/2828/29
Revenue Growth85%(39%)66%85%
Gross Profit Growth632%11917%(118%)632%
EBITDA Growth-51%18%-
EBIT Growth53%13%28%53%
Net Profit Growth48%42%3%48%
FCF Growth-49%32%-

Data powered by FactSet, Inc. and Morningstar, Inc.

Aclarion Operational KPIs

Aclarion's revenue per employee in the last FY averaged $0.0M, while opex per employee averaged $1.2M for the same period.

Access forward-looking KPIs for Aclarion
LTMLast FY202320242025202620272028
Revenue per Employee-$0.0M---
Opex per Employee-$1.2M---
S&M Expenses to Revenue2554%2510%1004%2136%2510%
G&A Expenses to Revenue4608%5447%4304%7893%5447%
R&D Expenses to Revenue968%1365%1158%1944%1365%
Opex to Revenue-9322%6468%11972%9322%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Aclarion Competitors

Aclarion competitors include NRGene, Pheton Holdings, HeartSciences, AMA Corp, Media Lab, Predilife, Synthetic MR, Kontigo Care, Servana and CurveBeam AI.

Most Aclarion public comparables operate across Healthcare Software, Medical Imaging & Diagnostics, B2B SaaS, Vertical SaaS, HealthTech and Longevity.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
NRGene0.7x-(2.4x)-
Pheton Holdings----
HeartSciences2523.4x-(1.3x)(1.5x)
AMA Corp4.2x-(1.7x)-
Media Lab4.1x-17.8x-
Predilife13.0x-(3.4x)-
Synthetic MR0.4x0.4x(0.6x)(1.8x)
Kontigo Care1.3x-10.8x-

This data is available for Pro users. Sign up to see all Aclarion competitors and their valuation data.

Start Free Trial

Aclarion VC Funding History

Before going public, Aclarion raised $21M in total equity funding, across 5 rounds.


Aclarion Funding Rounds

DateStageInvestorsRaisedValuationRev. MultipleDeal Summary
Feb-19Series B-$9M--
Aug-17Seed-$2M--
Sep-16Series B-$3M--
Mar-15Seed-$2M--
Dec-13Series A-$5M--

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Aclarion

When was Aclarion founded?Aclarion was founded in 2015.
Where is Aclarion headquartered?Aclarion is headquartered in United States.
How many employees does Aclarion have?As of today, Aclarion has over 6 employees.
Is Aclarion publicly listed?Yes, Aclarion is a public company listed on Nasdaq.
What is the stock symbol of Aclarion?Aclarion trades under ACON ticker.
When did Aclarion go public?Aclarion went public in 2022.
Who are competitors of Aclarion?Aclarion main competitors include NRGene, Pheton Holdings, HeartSciences, AMA Corp, Media Lab, Predilife, Synthetic MR, Kontigo Care, Servana, CurveBeam AI.
What is the current market cap of Aclarion?Aclarion's current market cap is $8M.
What is the current revenue of Aclarion?Aclarion's last 12 months revenue is $116K.
What is the current revenue growth of Aclarion?Aclarion revenue growth (NTM/LTM) is 85%.
What is the current EV/Revenue multiple of Aclarion?Current revenue multiple of Aclarion is (72.1x).
Is Aclarion profitable?No, Aclarion is not profitable.
What is the current net income of Aclarion?Aclarion's last 12 months net income is ($9M).
How many companies Aclarion has acquired to date?Aclarion hasn't acquired any companies yet (or none have been disclosed publicly).
In how many companies Aclarion has invested to date?Aclarion hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to Aclarion

Lists including Aclarion

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial